CompletedNCT02997423
Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
Studying Giant cell glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Iowa
- Principal Investigator
- Corinne E Griguer, PhDUniversity of Iowa
- Enrollment
- 153 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2016 – 2022
Study locations (19)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- UC Davis, Sacramento, California, United States
- University of Miami, Miami, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Washington University Medical School, St Louis, Missouri, United States
- Columbia University Medical Center, New York, New York, United States
- University of Rochester Medical Center, Rochester, New York, United States
- SUNY Stony Brook, Stony Brook, New York, United States
- Montefiore Medical Center, The Bronx, New York, United States
- University of Cincinnati, Cincinnati, Ohio, United States
- Ohio State University, Columbus, Ohio, United States
- Oregon Health & Science University, Portland, Oregon, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- +4 more locations on ClinicalTrials.gov
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS) · NeuroNEXT Network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02997423 on ClinicalTrials.govOther trials for Giant cell glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06176066PH Sensitive MRI Based Resections of GlioblastomaUniversity of California, Los Angeles
- RECRUITINGNCT05864976Neurosurgical Neuronavigation Using Resting State MRI and Machine LearningWashington University School of Medicine
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05685004Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)TVAX Biomedical
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04922723Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in GlioblastomaWest Virginia University
- RECRUITINGPHASE1NCT05083754Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With GlioblastomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- ACTIVE NOT RECRUITINGPHASE1NCT04968366Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After SurgeryBeijing Tiantan Hospital
- ACTIVE NOT RECRUITINGPHASE2NCT04574856Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed GlioblastomaUniversity of Michigan Rogel Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT04116411A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma PatientsCecilia Soderberg-Naucler